Literature DB >> 31771998

Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.

Athénaïs Boucly1,2,3, Capucine Morélot-Panzini4,5, Gilles Garcia1,3,6, Jason Weatherald7,8, Xavier Jaïs1,2,3, Laurent Savale1,2,3, David Montani1,2,3, Marc Humbert1,2,3, Thomas Similowski4,5, Olivier Sitbon1,2,3,9, Pierantonio Laveneziana10,11,9.   

Abstract

Dynamic hyperinflation is observed during exercise in 60% of patients with clinically stable pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), intensifying exertional dyspnoea. The impact of dynamic changes in respiratory mechanics during exercise on qualitative dimensions of dyspnoea in these patients has not been evaluated.26 patients (PAH n=17; CTEPH n=9) performed an incremental symptom-limited cycle exercise test. Minute ventilation (V'E), breathing pattern, operating lung volumes and dyspnoea intensity were assessed throughout exercise. Dyspnoea quality was serially assessed during exercise using a three-item questionnaire (dyspnoea descriptors). The inflection point of tidal volume (V T) relative to V'E was determined for each incremental test. Changes in inspiratory capacity during exercise defined two groups of patients: hyperinflators (65%) and non-hyperinflators (35%). Multidimensional characterisation of dyspnoea was performed after exercise using the Multidimensional Dyspnea Profile.In hyperinflators, inspiratory capacity decreased progressively throughout exercise by 0.36 L, while remaining stable in non-hyperinflators. The "work/effort" descriptor was most frequently selected throughout exercise in both types of patients (65% of all responses). At the V T/V'E inflection, work/effort plateaued while "unsatisfied inspiration" descriptors became selected predominantly only in hyperinflators (77% of all responses). In the affective domain, the emotion most frequently associated with dyspnoea was anxiety.In pulmonary hypertension patients who develop hyperinflation during exercise, dyspnoea descriptors referring to unsatisfied inspiration become predominant following the V T/V'E inflection. As these descriptors are generally associated with more negative emotional experiences, delaying or preventing the V T/V'E inflection may have important implications for symptom management in patients with pulmonary hypertension.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 31771998     DOI: 10.1183/13993003.02108-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension.

Authors:  Farbod N Rahaghi; Megan Trieu; Faisal Shaikh; Fereidoun Abtin; Alejandro A Diaz; Lloyd L Liang; Igor Barjaktarevic; Richard N Channick; Raúl San José Estépar; George R Washko; Rajan Saggar
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 30.528

Review 2.  Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension.

Authors:  Ioanna Mitrouska; Maria Bolaki; Katerina Vaporidi; Dimitris Georgopoulos
Journal:  Pulm Circ       Date:  2022-03-23       Impact factor: 2.886

3.  lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia.

Authors:  Yiying Li; Junting Zhang; Hanliang Sun; Yujie Chen; Wendi Li; Xiufeng Yu; Xijuan Zhao; Lixin Zhang; Jianfeng Yang; Wei Xin; Yuan Jiang; Guilin Wang; Wenbin Shi; Daling Zhu
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

Review 4.  Measurement and Interpretation of Exercise Ventilatory Efficiency.

Authors:  Devin B Phillips; Sophie É Collins; Michael K Stickland
Journal:  Front Physiol       Date:  2020-06-25       Impact factor: 4.566

5.  Double Trouble: Airflow and Pulmonary Vascular Obstruction.

Authors:  Michael H Lee; Brian B Graham; Todd M Bull
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 21.405

6.  Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.

Authors:  Marco Guazzi; Matthias Wilhelm; Martin Halle; Emeline Van Craenenbroeck; Hareld Kemps; Rudolph A de Boer; Andrew J S Coats; Lars Lund; Donna Mancini; Barry Borlaug; Gerasimos Filippatos; Burkert Pieske
Journal:  Eur J Heart Fail       Date:  2022-07-31       Impact factor: 17.349

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.